These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34927775)

  • 21. Analysis of CARD14 Polymorphisms in Pityriasis Rubra Pilaris: Activation of NF-κB.
    Li Q; Jin Chung H; Ross N; Keller M; Andrews J; Kingman J; Sarig O; Fuchs-Telem D; Sprecher E; Uitto J
    J Invest Dermatol; 2015 Jul; 135(7):1905-1908. PubMed ID: 25734815
    [No Abstract]   [Full Text] [Related]  

  • 22. The management and genetic background of pityriasis rubra pilaris: a single-centre experience.
    Gál B; Göblös A; Danis J; Farkas K; Sulák A; Varga E; Nagy N; Széll M; Kemény L; Bata-Csörgő Z
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):944-949. PubMed ID: 30697821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a pathogenic
    Nielsen RM; Gram SB; Bygum A
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14.
    Lwin SM; Hsu CK; Liu L; Huang HY; Levell NJ; McGrath JA
    Br J Dermatol; 2018 Apr; 178(4):969-972. PubMed ID: 28301045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updates on Pityriasis Rubra Pilaris: A Scoping Review.
    Zhou T; Al Muqrin A; Abu-Hilal M
    J Cutan Med Surg; 2024; 28(2):158-166. PubMed ID: 38174859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
    Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
    JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered replication stress response due to CARD14 mutations promotes recombination-induced revertant mosaicism.
    Miyauchi T; Suzuki S; Takeda M; Peh JT; Aiba M; Natsuga K; Fujita Y; Takeichi T; Sakamoto T; Akiyama M; Shimizu H; Nomura T
    Am J Hum Genet; 2021 Jun; 108(6):1026-1039. PubMed ID: 34004138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular identification of the PSORS2 locus: mutations and polymorphisms in CARD14 gene].
    Dereure O
    Ann Dermatol Venereol; 2013 Jan; 140(1):65-6. PubMed ID: 23328365
    [No Abstract]   [Full Text] [Related]  

  • 29. Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.
    Joshi TP; Duvic M
    Am J Clin Dermatol; 2024 Mar; 25(2):243-259. PubMed ID: 38159213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune-regulatory genes as possible modifiers of familial pityriasis rubra pilaris - lessons from a family with PRP and psoriasis.
    Spoerri I; Herms S; Eytan O; Sarig O; Heinimann K; Sprecher E; Itin PH; Burger B
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):e389-e392. PubMed ID: 29704870
    [No Abstract]   [Full Text] [Related]  

  • 31. Report of a case with CARD14-associated papulosquamous eruptions and multiple skin cancers.
    Hsu CJ; Tsai TF
    Photodermatol Photoimmunol Photomed; 2024 May; 40(3):e12969. PubMed ID: 38618665
    [No Abstract]   [Full Text] [Related]  

  • 32. Choosing the right biologic for psoriatic patients may be in the cards.
    Heymann WR
    J Am Acad Dermatol; 2018 Sep; 79(3):441-442. PubMed ID: 29969699
    [No Abstract]   [Full Text] [Related]  

  • 33. A Review on Pityriasis Rubra Pilaris.
    Wang D; Chong VC; Chong WS; Oon HH
    Am J Clin Dermatol; 2018 Jun; 19(3):377-390. PubMed ID: 29302927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A patient with CARD14-associated papulosquamous eruptions showing atopic dermatitis-like features.
    Takeichi T; Terawaki S; Kubota Y; Ito Y; Tanahashi K; Muro Y; Akiyama M
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e58-e59. PubMed ID: 32619277
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation.
    Podlipnik S; Castellanos-Moreira R; Florez-Enrich H; Arostegui JI; Mascaró JM
    Australas J Dermatol; 2018 Feb; 59(1):e70-e73. PubMed ID: 28776328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologics for inherited disorders of keratinisation: A systematic review.
    Chen MKY; Flanagan AL; Sebaratnam DF; Gu Y
    Australas J Dermatol; 2024 Mar; 65(2):185-214. PubMed ID: 38126177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and genetic characteristics of CARD14-associated papulosquamous eruption in a paediatric case.
    Bujan MM; Manzur G; Natale M; Valinotto L; Cervini AB
    Australas J Dermatol; 2024 Mar; 65(2):215-216. PubMed ID: 38066725
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and Genetic Heterogeneity of
    Israel L; Mellett M
    Front Immunol; 2018; 9():2239. PubMed ID: 30386326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two cases of CARD14-associated papulosquamous eruption from India.
    Chiramel MJ; Sathishkumar D; Edison ES; George R
    Pediatr Dermatol; 2020 Jul; 37(4):692-694. PubMed ID: 32323375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autoinflammatory diseases in dermatology: DITRA and CAMPS].
    Sugiura K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):169-173. PubMed ID: 28747603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.